Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 302 of 1,261
  1. US 11173100

    Multi-part dental cement

    KURARAY NORITAKE DENTAL INC. · Granted Nov 16, 2021 · Expires Nov 11, 2041

    granted
  2. US 11172694

    Core-shell structure with titanium dioxide core

    SOLID CHEMICALS GMBH · Granted Nov 16, 2021 · Expires Nov 11, 2041

    granted
  3. US 11174481

    Targeting ligands

    Arrowhead Pharmaceuticals, Inc. · Granted Nov 16, 2021 · Expires Nov 11, 2041

    granted
  4. EP 3906927

    VERWENDUNG VON DOPAMIN-D3-TEILAGONISTEN ZUR BEHANDLUNG VON STÖRUNGEN DES ZENTRALEN NERVENSYSTEMS

    BIOPROJET PHARMA [FR] · Granted Nov 10, 2021 · Expires Nov 5, 2041

    granted
  5. US 11166964

    Treatment for modulating gut microbiota

    GALMED RESEARCH AND DEVELOPMENT LTD · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted
  6. US 11166937

    Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders

    Amazentis SA · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted
  7. US 11166936

    Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity

    Auransa Inc. · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted
  8. US 11166942

    Inhibitors of integrated stress response pathway

    PRAXIS BIOTECH LLC · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted
  9. BR 112021015776

    Edição de gene para hemofilia a com expressão de fator viii melhorada

    BAYER HEALTHCARE LLC [US] · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted
  10. US 11167025

    Altering the immundominance hierarchy using a DNA vaccine expressing conserved regions

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted
  11. US 11168125

    Immunoglobulin chimeric monomer-dimer hybrids

    BIOVERATIV THERAPEUTICS INC. · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted
  12. US 11168303

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted
  13. US 11168083

    Inhibitors of Plasma Kallikrein and uses thereof

    Takeda Pharmaceutical Company Limited · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted
  14. US 11169142

    Viscoelastic analysis in patients with disease associated with cardiovascular system

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted
  15. US 11168325

    Methods for treatment of polycystic kidney disease

    The Board of Regents of the University of Texas System · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted
  16. US 11168316

    Chimeric clotting factors

    BIOVERATIV THERAPEUTICS INC. · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted
  17. US 11168310

    Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathy

    Entrada Therapeutics, Inc. · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted
  18. US 11168305

    Methods for the treatment of degenerative disc disease

    DiscGenics, Inc. · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted
  19. US 11168304

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted
  20. US 11168102

    Bicyclic heteroaryl compounds and uses thereof

    Revolution Medicines, Inc. · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted
  21. US 11168148

    Antibodies to oxidation-specific epitopes

    The Regents of the University of California · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted
  22. US 11168144

    Activatable anti-PDL1 antibodies, and methods of use thereof

    CytomX Therapeutics, Inc. · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted
  23. US 11168142

    Administration of kynurenine depleting enzymes for tumor therapy

    The Board of Regents of the University of Texas System · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted
  24. US 11168141

    Muscle targeting complexes and uses thereof for treating dystrophinopathies

    Dyne Therapeutics, Inc. · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.